TREATMENT OF CANCER ASSOCIATED WITH DYSREGULATED NOVEL OPEN READING FRAME PRODUCTS

Title:

TREATMENT OF CANCER ASSOCIATED WITH DYSREGULATED NOVEL OPEN READING FRAME PRODUCTS

Document Type and Number:

WIPO Patent Application WO/2022/130259

Kind Code:

A3

Abstract:

The present application features methods of treating a cancer associated with a dysregulated novel open reading frame (nORF) in which increased or reduced expression of the dysregulated nORF is associated with cancer.

More Like This:

WO/2020/191237	DUAL ACTIVITY SUPER TOXIC RNAI ACTIVE DSRNAS
WO/2004/052300	MODULATION OF ALPHA-METHYLACYL-COA RACEMASE EXPRESSION
JP2006500910	Means and methods for specifically regulating CNS and target genes of the eye and their identification methods

Inventors:

PRABAKARAN SUDHAKARAN (US)

Application Number:

PCT/IB2021/061801

Publication Date:

July 28, 2022

Filing Date:

December 15, 2021

Export Citation:

Click for automatic bibliography generation Help

Assignee:

CAMBRIDGE ENTPR LTD (GB)
INT CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY (IN)

International Classes:

C12N15/113

Domestic Patent References:

WO2020081556A2	2020-04-23
WO1999002724A2	1999-01-21

Foreign References:

US20200318196A1

2020-10-08

Download PDF:

View/Download PDF PDF Help

Previous Patent: METHODS OF BONDING COPPER AND ARTICLES FORMED THEREBY

Next Patent: STRUCTURED FILM AND OPTICAL ARTICLE INCLUDING STRUCTURED FILM